Follow
Amin Adibi
Title
Cited by
Cited by
Year
The projected economic and health burden of uncontrolled asthma in the United States
M Yaghoubi, A Adibi, A Safari, JM FitzGerald, M Sadatsafavi
American journal of respiratory and critical care medicine 200 (9), 1102-1112, 2019
1732019
Validation and Utility Testing of Clinical Prediction Models: Time to Change the Approach
A Adibi, M Sadatsafavi, JPA Ioannidis
JAMA, 2020
682020
The Acute COPD Exacerbation Prediction Tool (ACCEPT): a modelling study
A Adibi, DD Sin, A Safari, KM Johnson, SD Aaron, JM FitzGerald, ...
The Lancet Respiratory Medicine 8 (10), 1013-1021, 2020
492020
Cell Therapy for Intracranial Aneurysms: A Review
A Adibi, A Sen, AP Mitha
World neurosurgery 86, 390-398, 2016
212016
Combined endovascular coiling and intra-aneurysmal allogeneic mesenchymal stromal cell therapy for intracranial aneurysms in a rabbit model: a proof-of-concept study
A Adibi, M Eesa, JH Wong, A Sen, AP Mitha
Journal of neurointerventional surgery 9 (7), 707-712, 2017
202017
An individualized prediction model for long-term lung function trajectory and risk of COPD in the general population
W Chen, DD Sin, JM FitzGerald, A Safari, A Adibi, M Sadatsafavi
Chest 157 (3), 547-557, 2020
142020
Looking at the COPD spectrum through “PRISm”
A Adibi, M Sadatsafavi
European Respiratory Journal 55 (1), 2020
122020
Value judgments in a COVID-19 vaccination model: A case study in the need for public involvement in health-oriented modelling
S Harvard, E Winsberg, J Symons, A Adibi
Social Science & Medicine 286, 114323, 2021
102021
Development and validation of the Evaluation Platform In COPD (EPIC): a population-based outcomes model of COPD for Canada
M Sadatsafavi, S Ghanbarian, A Adibi, K Johnson, JM FitzGerald, ...
Medical Decision Making 39 (2), 152-167, 2019
102019
Cost effectiveness of case detection strategies for the early detection of COPD
KM Johnson, M Sadatsafavi, A Adibi, L Lynd, M Harrison, H Tavakoli, ...
Applied Health Economics and Health Policy 19 (2), 203-215, 2021
82021
Programmable Interface for Statistical & Simulation Models (PRISM): Towards Greater Accessibility of Clinical and Healthcare Decision Models
A Adibi, S Harvard, M Sadatsafavi
arXiv preprint arXiv:2202.08358, 2022
72022
Lowering the P Value Threshold
A Adibi, D Sin, M Sadatsafavi
JAMA 321 (15), 1532-1533, 2019
62019
Moving beyond AUC: decision curve analysis for quantifying net benefit of risk prediction models
M Sadatsafavi, A Adibi, M Puhan, A Gershon, SD Aaron, DD Sin
European Respiratory Journal 58 (5), 2021
52021
Cost-effectiveness of implementing objective diagnostic verification of asthma in the United States
M Yaghoubi, A Adibi, Z Zafari, JM FitzGerald, SD Aaron, KM Johnson, ...
Journal of Allergy and Clinical Immunology 145 (5), 1367-1377. e4, 2020
52020
Innovation in unruptured intracranial aneurysm coiling: At which price or efficacy are new technologies cost-effective?
D Ben-Israel, BL Belanger, A Adibi, M Eesa, AP Mitha, E Spackman
Plos one 16 (8), e0255870, 2021
32021
Mesenchymal stromal cells: Translational pathways to clinical adoption
H Peiman, S Viswanathan
Academic Press, 2016
32016
ACCEPT 2 0: Recalibrating and externally validating the Acute COPD exacerbation prediction tool (ACCEPT)
A Safari, A Adibi, DD Sin, TY Lee, JK Ho, M Sadatsafavi
EClinicalMedicine 51, 2022
22022
The hidden and unchecked judgement calls when using exacerbation history for managing COPD
M Sadatsafavi, SD Aaron, AS Gershon, M Puhand, A Adibi, DD Sin
Arch. bronconeumol.(Ed. impr.), 629-631, 2022
12022
Vaccination of front-line workers with the AstraZeneca COVID-19 vaccine: benefits in the face of increased risk for prothrombotic thrombocytopenia
A Adibi, M Mozafarihashjin, M Sadatsafavi
medRxiv, 2021.04. 11.21255138, 2021
12021
Combined Coiling and Allogeneic Mesenchymal Stem/Stromal Cell Therapy Could be a More Cost-effective Alternative to Coiling Alone
A Adibi, A Sen, AP Mitha
STROKE 47, 2016
1*2016
The system can't perform the operation now. Try again later.
Articles 1–20